 | Up a level |
Cazzaniga, S.; Heidemeyer, K.; Zahn, C. A.; Seyed Jafari, S. M.; Sauter, T. C.; Naldi, L; Borradori, L. (2024). Dermatological emergencies and determinants of hospitalization in Switzerland: A retrospective study. (In Press). Journal of the European Academy of Dermatology and Venereology : JEADV Wiley 10.1111/jdv.20176
Sechi, A; Song, J; Dell'Antonia, M; Heidemeyer, K; Piraccini, B M; Starace, M; Naldi, L (2023). Adverse events in patients treated with Jak-inhibitors for alopecia areata: a systematic review. (In Press). Journal of the European Academy of Dermatology and Venereology : JEADV Wiley 10.1111/jdv.19090
Pezzolo, E; Cazzaniga, S; Di Leo, S; Naldi, L (2022). Efficacy and safety of Dimethyl fumarate in comparison with conventional therapy for psoriasis: an Italian real-world clinical experience. Journal of the European Academy of Dermatology and Venereology : JEADV, 36(7), e534-e537. Wiley 10.1111/jdv.17997
Cazzaniga, S; Naldi, L (2022). Administrative data and scientific evidence: a lesson from France - the safety of systemic treatment for psoriasis during the COVID-19 pandemic. The British journal of dermatology, 186(1), pp. 7-8. Wiley 10.1111/bjd.20776
Gisondi, P; Cazzaniga, S; Di Leo, S; Piaserico, S; Bellinato, F; Pizzolato, M; Gatti, A; Eccher, A; Brunelli, M; Saraggi, D; Girolomoni, G; Naldi, L (2021). Impact of the COVID-19 pandemic on melanoma diagnosis. Journal of the European Academy of Dermatology and Venereology : JEADV, 35(11), e714-e715. Wiley 10.1111/jdv.17493
Piaserico, S; Gisondi, P; Cazzaniga, S; Girolomoni, G; Calzavara-Pinton, P G; Naldi, L (2021). Is SARS-CoV-2 screening test indicated for psoriasis patients candidate to biologic therapy? Journal of the European Academy of Dermatology and Venereology : JEADV, 35(6), e355-e357. Wiley 10.1111/jdv.17175
Gisondi, P; Facheris, P; Dapavo, P; Piaserico, S; Conti, A; Naldi, L; Cazzaniga, S; Malagoli, P; Costanzo, A (2020). The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience. The British journal of dermatology, 183(2), pp. 373-374. Wiley 10.1111/bjd.19158
Cazzaniga, S.; Anzengruber, F; Augustin, M; Boehncke, W H; Borradori, Luca; Conrad, C; Cozzio, A; Djamei, V; French, L E; Gilliet, M; Häusermann, P; Heidemeyer, Kristine; Itin, P; Kolios, A G A; Laffitte, E; Maul, J-T; Mainetti, C; Naldi, L; Navarini, A A; Rustenbach, S J; ... (2019). Linkage between patients' characteristics and prescribed systemic treatments for psoriasis: a semantic connectivity map analysis of the Swiss Dermatology Network for Targeted Therapies registry. Journal of the European Academy of Dermatology and Venereology : JEADV, 33(12), pp. 2313-2318. Wiley 10.1111/jdv.15983
Bettoli, V; Cazzaniga, Simone; Scuderi, V; Zedde, P; Di Landro, A; Naldi, L (2019). Hidradenitis suppurativa epidemiology: from the first Italian registry in 2009 to the most recent epidemiology updates - Italian Registry Hidradenitis Suppurativa project 2. Journal of the European Academy of Dermatology and Venereology : JEADV, 33(S6), pp. 4-6. Wiley 10.1111/jdv.15826
Cazzaniga, Simone; Naldi, L; Virgili, A; Di Landro, A; Simon, Dagmar; Corazza, M; Borghi, A (2019). An original exploration of genital lichen sclerosus: the semantic connectivity map. Journal of the European Academy of Dermatology and Venereology, 33(2), e59-e62. Blackwell 10.1111/jdv.15191
Cazzaniga, Simone; Naldi, L; Damiani, G; Atzori, L; Patta, F; Guidarelli, G; Bettoli, V (2018). Validation of a visual-aided questionnaire for the self-assessment of hidradenitits suppurativa. Journal of the European Academy of Dermatology and Venereology, 32(11), pp. 1993-1998. Blackwell 10.1111/jdv.15050
Cazzaniga, Simone; Scerri, L; Gabbud, J P; Arenberger, P; Borradori, Luca; Naldi, L (2018). Factors influencing sessions' and speakers' evaluation: an analysis of seven consecutive European Academy of Dermatology and Venereology congress editions. Journal of the European Academy of Dermatology and Venereology, 32(12), pp. 2307-2313. Wiley 10.1111/jdv.15178
Busard, C I; Cohen, A D; Wolf, P; Gkalpakiotis, S; Cazzaniga, Simone; Stern, R S; Hutten, B A; Feldhamer, I; Quehenberger, F; Lichem, R; Kojanova, M; Adenubiova, E; Addis, A; Naldi, L; Spuls, P I (2018). Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries. Journal of the European Academy of Dermatology and Venereology, 32(2), pp. 245-253. Blackwell 10.1111/jdv.14583
Cazzaniga, Simone; Apfelbacher, C; Diepgen, T; Ofenloch, R F; Weisshaar, E; Molin, S; Bauer, A; Mahler, V; Elsner, P; Schmitt, J; Ballmer-Weber, B K; Spring, P; Naldi, L; Borradori, Luca; Simon, Dagmar (2018). Patterns of chronic hand eczema: a semantic map analysis of the CARPE registry data. British journal of dermatology, 178(1), pp. 229-237. Wiley-Blackwell 10.1111/bjd.15660
Naldi, L; Cazzaniga, Simone; di Mercurio, M; Grossi, E; Addis, A (2017). Inequalities in access to biological treatments for psoriasis: Results from the Italian Psocare Registry. British journal of dermatology, 176(5), pp. 1331-1338. Wiley-Blackwell 10.1111/bjd.15234
Virgili, A; Borghi, A; Cazzaniga, Simone; Di Landro, A; Naldi, L; Minghetti, S; Verrone, A; Stroppiana, E; Caproni, M; Nasca, M R; D'Antuono, A; Papini, M; Di Lernia, V; Corazza, M (2017). New insights into potential risk factors and associations in genital lichen sclerosus: Data from a multicentre Italian study on 729 consecutive cases. Journal of the European Academy of Dermatology and Venereology, 31(4), pp. 699-704. Blackwell 10.1111/jdv.13867
Naldi, L; Cazzaniga, Simone (2016). Prediction of high total naevus count to estimate melanoma risk. We need more, don't we? British journal of dermatology, 174(2), pp. 261-262. Wiley-Blackwell 10.1111/bjd.14334
Ribero, S; Stieger, Marco; Quaglino, P; Hongang, T; Bornstein, Michael; Naldi, L; Borradori, Luca (2015). Efficacy of topical tacrolimus for oral lichen planus: real-life experience in a retrospective cohort of patients with a review of the literature. Journal of the European Academy of Dermatology and Venereology, 29(6), pp. 1107-1113. Blackwell 10.1111/jdv.12758
Parlar, B; Blazek, Claudia Rosa; Cazzaniga, S; Naldi, L; Klötgen, Hans-Willhelm; Borradori, Luca; Büttiker, Urs (2014). Treatment of lower extremity telangiectasias in women by foam sclerotherapy vs. Nd:YAG laser: a prospective, comparative, randomized, open-label trial. Journal of the European Academy of Dermatology and Venereology, 29(3), pp. 549-554. Blackwell 10.1111/jdv.12627
Cortés, B; Khelifa, E; Clivaz, L; Cazzaniga, S; Saurat, J H; Naldi, L; Borradori, L (2012). Mortality rate in bullous pemphigoid: a retrospective monocentric cohort study. Dermatology, 225(4), pp. 320-5. Basel: Karger 10.1159/000345625
della Torre, R; Combescure, C; Cortés, B; Marazza, G; Beltraminelli, H; Naldi, L; Borradori, L (2012). Clinical presentation and diagnostic delay in bullous pemphigoid: a prospective nationwide cohort. British journal of dermatology, 167(5), pp. 1111-7. Oxford: Wiley-Blackwell 10.1111/j.1365-2133.2012.11108.x
Della Torre, R; Naldi, L; Borradori, L (2012). Una causa frequente di prurito diffuso nel soggetto anziano: il pemfigoide bolloso. Tribuna medica ticinese, pp. 179-185. Locarno: Ordine dei medici del cantone Ticino OMCT
Cortés, B; Marazza, G; Naldi, L; Combescure, C; Borradori, L; Autoimmune Bullous Disease Swiss Study Group, (2011). Mortality of bullous pemphigoid in Switzerland: a prospective study. British journal of dermatology, 165(2), pp. 368-74. Oxford: Wiley-Blackwell 10.1111/j.1365-2133.2011.10413.x
Marazza, G; Pham, H C; Schärer, L; Pedrazzetti, P P; Hunziker, T; Trüeb, R M; Hohl, D; Itin, P; Lautenschlager, S; Naldi, L; Borradori, L (2009). Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. British journal of dermatology, 161(4), pp. 861-8. Oxford: Wiley-Blackwell 10.1111/j.1365-2133.2009.09300.x
